Next, since cancer stem cells (CSCs) play a critical role in cancer recurrence and resistance to drugs, we sought to assess the effect of DCN-deficient fibroblasts on the response of BC cells to chemotherapeutic drugs. This evidence concerns the gene DCN and breast cancer.